Formulation And Assessment Of Transdermal Patches Containing Sustained-Release Haloperidol For The Treatment Of Antipsychotic Illness. Int. J. Environ. Sci. [Internet]. 2025 Jun. 24 [cited 2026 Aug. 6];:1646-51. Available from: https://theaspd.com/index.php/ijes/article/view/3101